Live Breaking News & Updates on Amphotericin B

Stay updated with breaking news from Amphotericin b. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Government imposes restrictions on export of Amphotericin-B injections


Government imposes restrictions on export of Amphotericin-B injections
SECTIONS
Last Updated: Jun 01, 2021, 02:50 PM IST
Share
Synopsis
According to a notification issued by the Directorate General of Foreign Trade (DGFT), export of the injections have been put in the restricted category. This means that an exporter would need permission or licence from the directorate for its outbound shipments.
The decision has been taken in view of rising cases of black fungus in the country.
The government on Tuesday imposed curbs on export of Amphotericin-B injections that are used for treatment of mucormycosis or black fungus infections.
According to a notification issued by the Directorate General of Foreign Trade (DGFT), export of the injections have been put in the restricted category. This means that an exporter would need permission or licence from the directorate for its outbound shipments. ....

Directorate General , Foreign Trade , Amphotericinb Injections , Amphotericin B , Black Fungus , Black Fungus Medicine , Directorate General Of Foreign Trade , இயக்குநரகம் ஜநரல் , வெளிநாட்டு வர்த்தகம் , கருப்பு பூஞ்சை , இயக்குநரகம் ஜநரல் ஆஃப் வெளிநாட்டு வர்த்தகம் ,

Celon Laboratories launches Amphotericin B Emulsion for Mucormycosis


Celon Laboratories launches Amphotericin B Emulsion for Mucormycosis
June 01, 2021
Celon will manufacture 10,000 vials per day
Specialty biopharmaceutical manufacturer, Celon Laboratories, has launched an alternative drug - Amphotericin B Emulsion, for the treatment of Mucormycosis, commonly known as Black Fungus.
Amphotericin B, is crucial to the treatment of Mucormycosis, of which a sudden resurgence is being witnessed off late among covid19 patients, across India.
Though Hyderabad-based Celon has been manufacturing Liposomal Amphotericin B since 2013, market demands were not met due to the unavailability of a critical ingredient sourced from Germany lipoids. To bypass the bottleneck caused by this sourcing obstacle and increase production of this medication, Celon developed an alternative, an emulsion-based formulation. ....

Bm Nagesh Kumar , Celon Laboratories , Hyderabad Based Celon , Managing Director , Celon Labs , Black Fungus , Amphotericin B , நிர்வகித்தல் இயக்குனர் , கருப்பு பூஞ்சை ,